268 related articles for article (PubMed ID: 31648319)
1. The transcriptome of CMML monocytes is highly inflammatory and reflects leukemia-specific and age-related alterations.
Franzini A; Pomicter AD; Yan D; Khorashad JS; Tantravahi SK; Than H; Ahmann JM; O'Hare T; Deininger MW
Blood Adv; 2019 Oct; 3(20):2949-2961. PubMed ID: 31648319
[TBL] [Abstract][Full Text] [Related]
2. Age-related mutations and chronic myelomonocytic leukemia.
Mason CC; Khorashad JS; Tantravahi SK; Kelley TW; Zabriskie MS; Yan D; Pomicter AD; Reynolds KR; Eiring AM; Kronenberg Z; Sherman RL; Tyner JW; Dalley BK; Dao KH; Yandell M; Druker BJ; Gotlib J; O'Hare T; Deininger MW
Leukemia; 2016 Apr; 30(4):906-13. PubMed ID: 26648538
[TBL] [Abstract][Full Text] [Related]
3. Myelodysplastic syndromes without peripheral monocytosis but with evidence of marrow monocytosis share clinical and molecular characteristics with CMML.
Schuler E; Frank F; Hildebrandt B; Betz B; Strupp C; Rudelius M; Aul C; Schroeder T; Gattermann N; Haas R; Germing U
Leuk Res; 2018 Feb; 65():1-4. PubMed ID: 29216536
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneous expression of cytokines accounts for clinical diversity and refines prognostication in CMML.
Niyongere S; Lucas N; Zhou JM; Sansil S; Pomicter AD; Balasis ME; Robinson J; Kroeger J; Zhang Q; Zhao YL; Ball M; Komrokji R; List A; Deininger MW; Fridley BL; Santini V; Solary E; Padron E
Leukemia; 2019 Jan; 33(1):205-216. PubMed ID: 30026572
[TBL] [Abstract][Full Text] [Related]
5. The use of targeted sequencing and flow cytometry to identify patients with a clinically significant monocytosis.
Cargo C; Cullen M; Taylor J; Short M; Glover P; Van Hoppe S; Smith A; Evans P; Crouch S
Blood; 2019 Mar; 133(12):1325-1334. PubMed ID: 30606702
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cells in chronic myelomonocytic leukaemia.
Vuckovic S; Fearnley DB; Gunningham S; Spearing RL; Patton WN; Hart DN
Br J Haematol; 1999 Jun; 105(4):974-85. PubMed ID: 10554809
[TBL] [Abstract][Full Text] [Related]
7. Tumor microenvironment and clonal monocytes from chronic myelomonocytic leukemia induce a procoagulant climate.
Zannoni J; Mauz N; Seyve L; Meunier M; Pernet-Gallay K; Brault J; Jouzier C; Laurin D; Pezet M; Pernollet M; Cahn JY; Cognasse F; Polack B; Park S
Blood Adv; 2019 Jun; 3(12):1868-1880. PubMed ID: 31221660
[TBL] [Abstract][Full Text] [Related]
8. Targeted sequencing aids in identifying clonality in chronic myelomonocytic leukemia.
Hwang SM; Kim SM; Nam Y; Kim J; Kim S; Ahn YO; Park Y; Yoon SS; Shin S; Kwon S; Lee DS
Leuk Res; 2019 Sep; 84():106190. PubMed ID: 31377458
[TBL] [Abstract][Full Text] [Related]
9. How I treat chronic myelomonocytic leukemia.
Solary E; Itzykson R
Blood; 2017 Jul; 130(2):126-136. PubMed ID: 28572287
[TBL] [Abstract][Full Text] [Related]
10. Application of immunophenotypic analysis in distinguishing chronic myelomonocytic leukemia from reactive monocytosis.
Feng R; Bhatt VR; Fu K; Pirruccello S; Yuan J
Cytometry B Clin Cytom; 2018 Nov; 94(6):901-909. PubMed ID: 30334354
[TBL] [Abstract][Full Text] [Related]
11. RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant.
Ricci C; Fermo E; Corti S; Molteni M; Faricciotti A; Cortelezzi A; Lambertenghi Deliliers G; Beran M; Onida F
Clin Cancer Res; 2010 Apr; 16(8):2246-56. PubMed ID: 20371679
[TBL] [Abstract][Full Text] [Related]
12. Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia.
Geyer JT; Tam W; Liu YC; Chen Z; Wang SA; Bueso-Ramos C; Oak J; Arber DA; Hsi E; Rogers HJ; Levinson K; Bagg A; Hassane DC; Hasserjian RP; Orazi A
Mod Pathol; 2017 Sep; 30(9):1213-1222. PubMed ID: 28548124
[TBL] [Abstract][Full Text] [Related]
13. Genetic and epigenetic factors interacting with clonal hematopoiesis resulting in chronic myelomonocytic leukemia.
Carr RM; Patnaik MM
Curr Opin Hematol; 2020 Jan; 27(1):2-10. PubMed ID: 31688455
[TBL] [Abstract][Full Text] [Related]
14. Chronic myelomonocytic leukaemia stem cell transcriptomes anticipate disease morphology and outcome.
Wiseman DH; Baker SM; Dongre AV; Gurashi K; Storer JA; Somervaille TC; Batta K
EBioMedicine; 2020 Aug; 58():102904. PubMed ID: 32763828
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia.
Ouyang Y; Qiao C; Chen Y; Zhang SJ
Oncotarget; 2017 Mar; 8(13):20834-20841. PubMed ID: 28209919
[TBL] [Abstract][Full Text] [Related]
16. Cytokine-like protein 1-induced survival of monocytes suggests a combined strategy targeting MCL1 and MAPK in CMML.
Sevin M; Debeurme F; Laplane L; Badel S; Morabito M; Newman HL; Torres-Martin M; Yang Q; Badaoui B; Wagner-Ballon O; Saada V; Sélimoglu-Buet D; Kraus-Berthier L; Banquet S; Derreal A; Fenaux P; Itzykson R; Braun T; Etienne G; Berthon C; Thépot S; Kepp O; Kroemer G; Padron E; Figueroa ME; Droin N; Solary E
Blood; 2021 Jun; 137(24):3390-3402. PubMed ID: 33690800
[TBL] [Abstract][Full Text] [Related]
17. Oligo-monocytic CMML and other pre-CMML states: Clinical impact, prognostication and management.
Valent P
Best Pract Res Clin Haematol; 2020 Jun; 33(2):101137. PubMed ID: 32460976
[TBL] [Abstract][Full Text] [Related]
18. Role of the bone marrow immune microenvironment in chronic myelomonocytic leukemia pathogenesis: novel mechanisms and insights into clonal propagation.
Mangaonkar AA; Patnaik MM
Leuk Lymphoma; 2022 Aug; 63(8):1792-1800. PubMed ID: 35377828
[TBL] [Abstract][Full Text] [Related]
19. Chronic myelomonocytic leukemia masquerading as cutaneous indeterminate dendritic cell tumor: Expanding the spectrum of skin lesions in chronic myelomonocytic leukemia.
Loghavi S; Curry JL; Garcia-Manero G; Patel KP; Xu J; Khoury JD; Torres-Cabala CA; Nagarajan P; Aung PP; Gibson BR; Goodwin BP; Kelly BC; Korivi BR; Medeiros LJ; Prieto VG; Kantarjian HM; Bueso-Ramos CE; Tetzlaff MT
J Cutan Pathol; 2017 Dec; 44(12):1075-1079. PubMed ID: 28885734
[TBL] [Abstract][Full Text] [Related]
20. Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure.
Abplanalp WT; Mas-Peiro S; Cremer S; John D; Dimmeler S; Zeiher AM
JAMA Cardiol; 2020 Oct; 5(10):1170-1175. PubMed ID: 32639511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
